Skip to main content
Equibles

Comprehensive Financial Management LLC

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1799802 Los Gatos, CA
Back to RXRX Full portfolio

Position in RXRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,456,754
+$565,137 QoQ
Shares Held
941,895
0.0% QoQ
Ownership
0.176%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#35
of 344 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RXRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Comprehensive Financial Management LLC holds $11,980,338 across 5 Biotechnology names. RXRX ranks #2 (28.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NAUT
Nautilus Biotechnology, Inc.
 2,207,619 $4,128,247
2 RXRX
Recursion Pharmaceuticals, Inc.
This page 		941,895 $3,456,754
3 TWST
Twist Bioscience Corp
 26,273 $2,702,966
4 EIKN
Eikon Therapeutics, Inc.
 116,276 $1,517,401
5 DNA
Ginkgo Bioworks Holdings, Inc.
 17,656 $174,970

All Filings in RXRX

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,456,754 941,895
2026-03-31 $2,891,617 941,895
2025-12-31 $3,852,350 941,895
2025-09-30 $4,596,447 941,895
2025-06-30 $4,765,988 941,895
2025-03-31 $4,982,624 941,895
2024-12-31 $6,367,210 941,895
2024-09-30 $6,207,088 941,895
2024-06-30 $7,064,212 941,895
2024-03-31 $9,390,693 941,895
2023-12-31 $9,287,084 941,895
2023-09-30 $7,205,496 941,895
2023-06-30 $8,287,180 1,109,395
2023-03-31 $7,399,664 1,109,395
2022-12-31 $8,553,435 1,109,395
2022-09-30 $11,803,962 1,109,395
2022-06-30 $9,030,475 1,109,395
2022-03-31 $7,943,268 1,109,395
2021-12-31 $19,003,936 1,109,395
2021-09-30 $25,527,178 1,109,395
2021-06-30 $40,492,917 1,109,395